Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/
(Photo: Business Wire)
Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants of our cells.
Timeline will be the first consumer product in the world to contain precisely calibrated doses of Mitopure that have been clinically shown to improve the mitochondrial and cellular health of the skeletal muscle. Timeline will be available to purchase online for consumers in the United States in the first half of 2020 at www.timelinenutrition.com.
“After a decade of research and trials to perfect Mitopure, we’re giving consumers access to a product that improves their muscle health by targeting aging mitochondria,” said Amazentis CEO and Co-Founder, Chris Rinsch.
“For years, consumers have been searching for a solution to maintain muscle health as they age; Timeline provides a new way to proactively take control of cellular health early on, which directly impacts the aging process,” added Amazentis Co-Founder and Chairman Patrick Aebischer.
The World Economic Forum engages societal leaders to shape global, regional and industry agendas. As part of the Forum, there will be a panel discussion on January 23rd at 15:00 CET at the House of Switzerland, focusing on the innovations in the food and nutrition industry. During the conversation, Rinsch will share the health benefits of Timeline and Mitopure with the audience. The panel will be moderated by CNN Money Switzerland Anchor Anna Maria Montero and include:
- Nestlé Global Chairman of the Board, Paul Bulcke
- École Polytechnique Fédérale de Lausanne (EPFL) President, Martin Vetterli
- 3 Star Michelin Chef, Hôtel de Ville de Crissier, Franck Giovannini
- Amazentis CEO and Co-Founder, Chris Rinsch
Amazentis is an innovative life sciences company pioneering scientific breakthroughs in nutrition to manage health conditions linked to aging. The company’s lead ingredient, Mitopure™, has been favorably reviewed by the U.S. Food and Drug Administration (FDA) following a GRAS (generally recognized as safe) filing. Mitopure has been extensively evaluated pre-clinically and clinically to support its use in humans for nutritional supplementation.
About Timeline
Timeline is a novel nutrition brand developed by Amazentis on the belief that uncompromising research can unlock a new class of nutrition that is backed by cutting edge science. As scientists, we know that physical decline from aging can’t be stopped. However, through its groundbreaking science, Timeline is committed to developing products designed to help reduce the impact of time on health. For more information, please visit timelinenutrition.com.
About Mitopure
Mitopure is a highly pure form of Urolithin A, a bioactive dietary metabolite that is naturally produced when eating certain foods, such as the pomegranate, though it is difficult for most people to get enough of this specialized nutrient from food alone. Mitopure has been shown to improve mitochondrial function by stimulating mitophagy, a process by which aging and damaged mitochondria are cleared from the cell, leading to the growth of healthy mitochondria. For more information, please visit https://www.mitopure.com/.
About Amazentis
Amazentis is an innovative life science company that employs today’s leading research and clinical science to develop the next generation of products targeting mitochondrial health for advanced nutrition. For more information on Amazentis, please visit www.amazentis.com.
Related Links
https://www.timelinenutrition.com
https://www.mitopure.com
https://www.amazentis.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200123005820/en/
Contact information
Federico Luna
Chief Marketing Officer, Amazentis
press@amazentis.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aqara Smart Lock U200 Lite Brings Smart Access Control to More European Households17.6.2025 10:00:00 EEST | Press release
Aqara, global leader and pioneer in IoT, unveils the new Smart Lock U200 Lite, offering effortless access control, enhanced security, and a modern keyless lifestyle to more European households, particularly those seeking budget-friendly solutions. Designed for DIY installation, the U200 Lite features a retrofit design compatible with most Euro mortise locks. It also supports Matter over Thread to ensure compatibility with a wide range of connected devices and seamless integration into users’ existing smart home setup. Built upon the Thread protocol, which is purposely developed for IoT devices, the Smart Lock U200 Lite is Matter-certified and integrates with major platforms – including Alexa, Apple Home, Google Home, Home Assistant, and SmartThings – without the need for a proprietary hub1. As an integral part of a connected home, the U200 Lite can be integrated with a variety of smart devices, from video doorbells, surveillance cameras to smart sensors, enabling users to create a cust
Smoke Free Sweden: Oral Nicotine Pouches Are Game-changer for Women in Sweden's Smoke-free Success17.6.2025 09:32:00 EEST | Press release
New research from Smoke Free Sweden reveals oral nicotine pouches are a game-changer in Sweden’s path to becoming the world’s first smoke-free nation – and are driving unprecedented success among women. The report, Power in a Pouch, launched today in Strasbourg, shows pouches have been a decisive catalyst in Sweden’s public health success – especially for women, who are quitting smoking faster and more effectively than ever. Since their introduction in 2016, tobacco-free pouches have: Helped to accelerate the decline in smoking for both genders, with a nearly 200% rise in quit rates among women. Outperformed all other quit aids; women ranked pouches nearly three times higher than vapes and 56% higher than gum. Been identified by the research as the preferred quit aid for all ex-smokers for being clean, socially considerate and stigma-free. Driven a 49% drop in smoking among women, who historically quit at lower rates than men. “The evidence is crystal clear: nicotine pouches are the mo
CSG & AWS Expand Collaboration to Accelerate Cloud Transformation in Telecommunications & Financial Services17.6.2025 09:30:00 EEST | Press release
In arapidly evolving digital economy, telecommunications and financial services companies face mounting pressure to modernise, scale operations and unlock innovation—all while managing costs and navigating complex growth journeys. Today,CSG® (NASDAQ: CSGS) announced a new strategic collaboration agreement with Amazon Web Services (AWS) to fast-track cloud transformation across these industries. The initiative will come to life through advanced cloud-native technologies, cost optimisation and platform innovation. “As industries double down on cloud transformation, they need scalable, cost-efficient platforms that can evolve with them,” said Mayoor Mahendra, Vice President, Network Solutions, CSG. “Our extended collaboration with AWS amplifies the value of CSG’s Converged Mediation solution by pairing it with AWS’s global infrastructure. Together, we’re helping telco and banking and financial services leaders modernise faster, reduce costs and innovate with confidence.” Building on a lon
First Aero-Medical Cessna SkyCourier to be Delivered to Tassili Travail Aérien in Africa, Launching New Era of Medevac Services17.6.2025 09:30:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced today at the Paris Air Show that Tassili Travail Aérien (TTA) has signed a purchase agreement for two new Cessna SkyCourier aircraft, marking the first order of an aero-medical equipped SkyCourier and the first SkyCourier order in Africa. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250616699259/en/ Textron Aviation and Tassili Travail Aérien celebrate first aero-medical Cessna SkyCourier to be delivered in Africa, launching new era of medevac services. (Photo credit: Textron Aviation) Based in Algeria, TTA is a subsidiary of Sonatrach, the national state-owned oil and gas company. TTA provides passenger transportation, aero-medical evacuation, and other special mission services to the energy sector across Algeria. The Cessna SkyCourier is designed and manufactured by Textron Aviation. “The Cessna SkyCourier is a versatile aircraft capable of supporting c
PharmSight Strengthens Global Footprint with New Office in Zug (Switzerland); Launches Conversity’s AI Training Platform17.6.2025 09:30:00 EEST | Press release
PharmSight Research & Analytics today announces the opening of its European hub in Zug, Switzerland. Operating as PharmSight GmbH, this strategic expansion reinforces the company’s commitment to deliver data-driven insights for negotiation training, sales force optimization, and market access solutions in the heart of Europe’s pharmaceutical ecosystem. Leading PharmSight GmbH is Mr Gianclaudio Floria, recently appointed CEO with over 20 years of experience in commercial operations and strategic roles at industry giants like Amgen, BMS, Fresenius Kabi, Gilead, and Alexion. A published author and recognized thought leader, Mr. Floria brings extensive international expertise in Finance, M&A, Strategic Planning, and Market Access, reinforcing PharmSight’s vision for Europe. A cornerstone of the Zug launch is the debut of Conversity, an AI-driven training platform that leverages ultra-realistic avatars, scenario-based simulations, and real-time analytics to elevate negotiation and sales per
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom